LB1602 Skin cancer in skin of color transplant patients

Malignant skin lesions in transplant recipients

Several advances in the filed of organ transplantation in last decades have resulted in significant increase in the number and methods of transplantation. In this article various aspects of organ transplantation including immunosuppressive medications, common skin tumors seen in transplant recipients, possible mechanisms involved in increased incidence of skin tumors and finally preventive meas...

Skin Cancer and Sun protection in Skin of Color

Skin cancer in Yazd

Background and aim: Skin cancer is the most common human cancer. Ultraviolet radiation is now recognized as the most important risk factor for skin cancer development. Light skin colored individuals that spend more time outdoors in day are more susceptible to disease. In this study skin cancer situation in Yazd (located in a hot, dry and desert area) was reviewed.Materi...

Immunosuppressants and skin cancer in transplant patients: focus on rapamycin.

BACKGROUND The responsibility of immunosuppressants for the increased risk of skin cancers in organ transplant recipients is widely recognized. Discerning the role of each drug is complicated owing to the fact that most patients generally have combinations of several medications. OBJECTIVE This article will discuss the role of the main immunosuppressants in the pathogenesis of skin cancers. ...

Histopathologic evaluation of Verrucous skin lesions in renal transplant recipients

Background: Warts are common in renal allograft recipients (RAR) with reported incidence of 24% to 100%. These patients also demonstrate an accelerated malignant transformation of warts. Although in immunocompetent patients, the histology of common warts is quite predictable, this is not so in RAR. Objective: The purpose of this study was to evaluate the histopathologic findings of warty lesion...